Cargando…
Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice
Inflammatory bowel disease (IBD) is a type of chronic inflammatory disturbance that affects a number of individuals worldwide; the precise mechanism is unclear and treatment is frequently insufficient to maintain patients in remission. Saccharomyces boulardii is a thermophilic, non-pathogenic yeast...
Autores principales: | Zhou, Huan, Zhang, Hui-Jing, Guan, Lin, Zhang, Yi-Ning, Li, Yue, Sun, Ming-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236308/ https://www.ncbi.nlm.nih.gov/pubmed/30387820 http://dx.doi.org/10.3892/mmr.2018.9612 |
Ejemplares similares
-
Saccharomyces boulardii protects against murine experimental colitis by reshaping the gut microbiome and its metabolic profile
por: Gao, Hui, et al.
Publicado: (2023) -
Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice
por: Maioli, Tatiani Uceli, et al.
Publicado: (2014) -
Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice
por: Dong, Jin-Pei, et al.
Publicado: (2019) -
Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients
por: Sulik-Tyszka, Beata, et al.
Publicado: (2017) -
Biocontainment strategies for in vivo applications of Saccharomyces boulardii
por: Hedin, Karl Alex, et al.
Publicado: (2023)